NHS Fights To Revive £220M Drug Patent Suit At Top UK Court
By Paige Long ( April 14, 2021, 4:51 PM BST) -- The National Health Service argued at the U.K.'s highest court on Wednesday that its £220 million ($300 million) lawsuit accusing pharmaceutical giant Servier of dishonestly securing a patent for a blood pressure drug should be revived....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.